2016 annual financial data
Marker Therapeutics 2016 Net margin
Marker Therapeutics 2016 net margin with verified reported values.
Direct answer
Net margin was Not calculable.
Operating income was -8,492,000 USD and net income was -2,455,000 USD.
Operating cash flow was -6,509,921 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,492,000 USD
- Net income
- -2,455,000 USD
- Operating cash flow
- -6,509,921 USD